Staphylococcus pseudintermedius: The Bacteria That Lives on Every Dog's Skin

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated August 2026 · 9 min read

What Is Staphylococcus pseudintermedius?

Staphylococcus pseudintermedius is a gram-positive, coagulase-positive bacterium that lives permanently on the skin, in the nostrils, in the mouth, and around the anus of healthy dogs, and it is the primary bacterial cause of skin infection in the species. It is a commensal organism, meaning it normally coexists with its host without causing harm, and it only becomes a pathogen when skin defenses fail.

Carriage studies find S. pseudintermedius on 46 to 92% of clinically normal dogs, with the mucosal sites (nostrils, mouth, perineum) acting as the main reservoirs that reseed the coat during grooming and scratching. Because the organism is already present, a dog does not "catch" a staph infection from the environment in most cases. The infection comes from within.

Until 2005 this organism was misidentified in the veterinary literature as Staphylococcus intermedius. Molecular sequencing then split the group into three species, and retrospective work showed that essentially all canine clinical isolates previously called S. intermedius were in fact S. pseudintermedius (Devriese et al., 2005; Bannoehr et al., 2007). Older articles and even some current lab reports still use the old name, so the two terms describe the same clinical problem.

The species is distinct from Staphylococcus aureus, the dominant human staphylococcus. That distinction matters for zoonotic risk assessment, because S. pseudintermedius transmits to humans far less readily, though it is not impossible in immunocompromised owners.

Why Does a Normal Bacterium Cause Infection?

S. pseudintermedius causes disease when the skin barrier, the local immune response, or the microbial balance of the skin surface is disrupted, allowing a resident population to expand and invade the follicle. Pyoderma in dogs is therefore considered a secondary disease in the overwhelming majority of cases, and treating the infection without finding the trigger produces relapse.

The three most common underlying triggers are allergic skin disease (atopic dermatitis, flea allergy, cutaneous adverse food reaction), endocrinopathy (hypothyroidism, hyperadrenocorticism), and ectoparasites. Atopic dogs are particularly vulnerable: their corneocytes bind S. pseudintermedius significantly more avidly than those of healthy dogs, and their reduced ceramide content leaves a leakier stratum corneum (Simou et al., 2005).

The organism itself carries a substantial virulence toolkit. It expresses surface adhesins of the MSCRAMM family that anchor it to canine corneocytes, produces exfoliative toxins (ExpA, ExpB) that cleave desmoglein-1 and separate the epidermal layers, and secretes leukotoxins and proteases. It also forms biofilm, a polysaccharide matrix that can reduce antimicrobial penetration by orders of magnitude and helps explain why chronic lesions resist therapy.

Follicular anatomy adds one more factor. Canine hair follicles are compound, with multiple hairs emerging through a shared infundibulum, and the canine stratum corneum is thinner and has a higher pH than human skin. Both features favor bacterial colonization once surface conditions shift. Read more in our guide to dog skin barrier function.

How Do Veterinarians Diagnose a Staph Infection?

Diagnosis of S. pseudintermedius pyoderma rests on cytology, which visualizes cocci and neutrophils directly, and is confirmed by bacterial culture with antimicrobial susceptibility testing when resistance is suspected. Neither history nor lesion appearance alone is sufficient, because yeast, demodex, and dermatophytes can produce overlapping lesions.

Cytology is the fastest and most informative in-clinic test. An acetate tape preparation or direct impression smear stained with Diff-Quik reveals coccoid bacteria in pairs or short chains, often visible inside degenerate neutrophils. Intracellular cocci confirm active infection rather than surface contamination. Our articles on acetate tape preparation and skin impression smears cover the technique in detail.

Culture and susceptibility testing is indicated when cytology shows rods alongside cocci, when the dog has failed an appropriate course of therapy, when lesions are deep or nodular, or when there is recent antibiotic or hospital exposure. Laboratories screen for methicillin resistance using oxacillin or cefoxitin breakpoints, and confirm with mecA gene detection by PCR. A mecA-positive isolate is resistant to every beta-lactam, including all cephalosporins and amoxicillin-clavulanate, regardless of what the individual disc results appear to show. See how to read skin culture results.

If you are trying to work out whether your dog's lesions look bacterial, fungal, or parasitic before your appointment, the Dog Skin Condition Checker can help you organize what to describe to your veterinarian.

Signs and Symptoms to Watch For

Staphylococcal pyoderma is classified by depth, and depth determines both treatment duration and prognosis. The clinical picture differs meaningfully between the three tiers.

What Is MRSP and Why Does Resistance Matter?

Methicillin-resistant Staphylococcus pseudintermedius, or MRSP, is a strain carrying the mecA gene, which encodes an altered penicillin-binding protein (PBP2a) with low affinity for beta-lactam antibiotics, rendering the entire beta-lactam class ineffective. MRSP was first described in dogs in the early 2000s and spread rapidly through international clonal lineages such as ST71 in Europe and ST68 in North America.

Prevalence varies sharply by population. Isolates from first-opinion practice show methicillin resistance in a minority of cases, while referral dermatology caseloads have reported figures approaching or exceeding 30%. Crucially, MRSP strains are usually multidrug resistant, not just beta-lactam resistant: many carry additional resistance to fluoroquinolones, macrolides, lincosamides, tetracyclines, and potentiated sulfonamides simultaneously, leaving very few oral options.

Documented risk factors for MRSP include prior antimicrobial exposure (especially repeated courses), recent hospitalization or surgery, and previous glucocorticoid therapy. There is no way to distinguish MRSP from susceptible S. pseudintermedius on cytology or by lesion appearance. Culture is the only route.

The practical consequence is that reflexively reaching for another oral antibiotic when a skin infection recurs is now the wrong move. It selects for resistance and delays the search for the underlying trigger. See why dogs keep getting skin infections for a fuller discussion of relapse drivers.

Treatment Options for Staphylococcal Pyoderma

Current international guidelines place topical antibacterial therapy as the first-line treatment for surface and superficial staphylococcal pyoderma, with systemic antibiotics reserved for deep infection or cases where topical therapy is impractical (Hillier et al., 2014; Morris et al., 2017). The rationale is straightforward: topicals reach the target at concentrations thousands of times higher than blood levels achieve, and they exert no selection pressure on gut flora.

Chlorhexidine gluconate is the best-evidenced topical antibacterial in dogs. A 2% formulation used twice weekly has resolved superficial pyoderma as a sole therapy in controlled trials, with efficacy comparable to systemic amoxicillin-clavulanate (Borio et al., 2015). Chlorhexidine is a cationic bisbiguanide: it binds the negatively charged bacterial cell wall, disrupts membrane integrity, and causes cytoplasmic leakage. Because that mechanism is physical rather than enzymatic, MRSP strains remain fully susceptible to chlorhexidine. Our complete guide to chlorhexidine shampoo covers contact times and bathing frequency, and Chlorhexidine for Dogs summarizes the evidence base.

Contact time matters more than most owners realize. A 10 minute contact period before rinsing is the standard recommendation, and clipping matted or heavily haired regions substantially improves product penetration to the skin surface.

Once the active infection is controlled, the goal shifts to protecting a barrier that is often still inflamed and itchy. Barrier-directed bathing addresses the substrate rather than the organism. Itchy Skin Relief Shampoo is formulated with colloidal oatmeal and aloe. Colloidal oatmeal contains avenanthramides, phenolic compounds shown to inhibit NF-kB mediated inflammatory signaling and reduce histamine-driven pruritus, while its beta-glucan and polysaccharide fraction forms an occlusive film that lowers transepidermal water loss. Reducing the scratch cycle matters bacteriologically as well as symptomatically, because self-trauma is what mechanically drives commensal staphylococci into the follicle in the first place.

For deep pyoderma or confirmed MRSP, systemic therapy is chosen strictly on susceptibility results, and courses run long. Never stop a prescribed course at the point lesions look better.

Prevention and Long-Term Management

Preventing recurrent staphylococcal pyoderma means controlling the underlying disease, not eliminating the bacterium, because S. pseudintermedius cannot be permanently removed from a dog's skin and reseeds from mucosal sites within days of any decolonization attempt.

The first priority is diagnosing and managing the trigger. In practice that means allergy workup and control for atopic or food-allergic dogs, thyroid and adrenal testing in dogs with recurrent infection plus systemic signs, and year-round parasite prevention. A dog whose atopic dermatitis is well controlled will have dramatically fewer bacterial flares. See our guide to canine atopic dermatitis.

Proactive maintenance bathing is the second pillar. Weekly or twice-weekly antibacterial bathing during high-risk periods reduces surface bacterial load before it reaches infection threshold, and studies of proactive topical protocols show significantly extended relapse-free intervals compared with reactive treatment alone. Adjust frequency to the season and to the individual dog's flare pattern.

Environmental management deserves attention in multi-dog households and after hospitalization. S. pseudintermedius survives on bedding, brushes, collars, and grooming tables. Wash bedding weekly at the highest safe temperature, disinfect grooming tools, and avoid sharing brushes between dogs when one is actively infected.

Finally, resist antibiotic escalation. If infection recurs within weeks of finishing a course, the answer is culture plus a hunt for the underlying cause, not a stronger drug. Antimicrobial stewardship in companion animals is a genuine public health concern, and the topical-first approach is the single most effective stewardship tool available to owners.

Frequently Asked Questions

Is Staphylococcus pseudintermedius contagious to humans?

Transmission to people is possible but uncommon. S. pseudintermedius is adapted to canine skin and colonizes humans poorly. Reported human infections are rare and cluster in immunocompromised individuals, veterinary staff, and owners with open wounds. Washing hands after applying topical treatment and avoiding face-licking during an active infection are reasonable precautions.

Can my dog be cured of staph bacteria completely?

No, and that is not the treatment goal. S. pseudintermedius is a normal resident of canine skin, nostrils, mouth, and perineum, and it recolonizes within days of any decolonization attempt. The clinical objective is restoring balance by resolving the overgrowth and correcting the underlying trigger that allowed it.

How long does it take to clear a staph skin infection in a dog?

Surface pyoderma typically resolves in 7 to 14 days with topical therapy alone. Superficial pyoderma requires a minimum of 21 days, or 7 days past complete clinical resolution. Deep pyoderma often needs 8 weeks or longer, continuing at least 14 days past resolution. Stopping early is the most common cause of relapse.

Does chlorhexidine still work against MRSP?

Yes. Chlorhexidine kills bacteria by physically disrupting the cell membrane, a mechanism unaffected by the mecA gene that confers methicillin resistance. Methicillin-resistant strains remain susceptible to 2% chlorhexidine gluconate at the concentrations used in veterinary topical products, which is why topical therapy is first-line in resistant cases.

Why does my dog keep getting staph infections?

Recurrence almost always signals an uncontrolled underlying condition rather than a resistant organism. Allergic skin disease is the most common driver, followed by hypothyroidism, hyperadrenocorticism, and parasites. If infection returns within eight weeks of successful treatment, request a full workup for the trigger alongside a bacterial culture.

Sources

1. Bannoehr J, Guardabassi L. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Veterinary Dermatology. 2012;23(4):253-266.
2. Hillier A, Lloyd DH, Weese JS, et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis. Veterinary Dermatology. 2014;25(3):163-175.
3. Morris DO, Loeffler A, Davis MF, et al. Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals. Veterinary Dermatology. 2017;28(3):304-e69.
4. Borio S, Colombo S, La Rosa G, et al. Effectiveness of a combined 2% chlorhexidine digluconate shampoo and solution protocol in the treatment of canine superficial pyoderma. Veterinary Dermatology. 2015;26(5):339-e72.
5. Bannoehr J, Ben Zakour NL, Waller AS, et al. Population genetic structure of the Staphylococcus intermedius group. Journal of Bacteriology. 2007;189(23):8685-8692.
6. Simou C, Thoday KL, Forsythe PJ, Hill PB. Adherence of Staphylococcus intermedius to corneocytes of healthy and atopic dogs. Veterinary Dermatology. 2005;16(6):385-391.

Related Reading

• Bacterial Skin Infections in Dogs: Understanding and Treating Pyoderma
• Chlorhexidine Shampoo for Dogs: Complete Veterinary Guide
• Why Does My Dog Keep Getting Skin Infections? Causes and Solutions
• Dog Skin Culture Results: How to Read Them

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.